The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Antibodies: A laboratory manual
J.L. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90307-1 · Cited by 5,089
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
The United States Pharmacopeial Convention
(1910) · The Boston Medical and Surgical Journal · doi:10.1056/nejm191002241620814 · Cited by 912
Mire-Sluis, A. R., Barrett, Y. C., Devanarayan, V., Koren, E., Liu, H., Maia, M., Parish, T., Scott, G., Shankar, G., Shores, E., et al. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.06.002 · Cited by 624
Self-citationDeSilva, B., Smith, W., Weiner, R., Kelley, M., Smolec, J., Lee, B., Khan, M., Tacey, R., Hill, H., & Celniker, A. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000003390.51761.3d · Cited by 623
Self-citationValidation of immunoassays for bioanalysis: a pharmaceutical industry perspective
Findlay, J. W. A., Smith, W. C., Lee, J. W., Nordblom, G. D., Das, I., DeSilva, B. S., Khan, M. N., & Bowsher, R. R. (2000) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(99)00244-7 · Cited by 589
Self-citationImmunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies
Shah, V. P., Midha, K. K., Dighe, S., McGilveray, I. J., Skelly, J. P., Yacobi, A., Layloff, T., Viswanathan, C. T., Cook, C. E., McDowall, R. D., et al. (1992) · Pharmaceutical Research · doi:10.1023/a:1015829422034 · Cited by 448
Factors influencing the immunogenicity of therapeutic proteins
Schellekens, H. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh1092 · Cited by 332
Koren, E., Smith, H. W., Shores, E., Shankar, G., Finco-Kent, D., Rup, B., Barrett, Y.-C., Devanarayan, V., Gorovits, B., Gupta, S., et al. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.01.001 · Cited by 328
Self-citationAndrews, N., Borrow, R., & Miller, E. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.780-786.2003 · Cited by 323
Borrow, R., Andrews, N., Goldblatt, D., & Miller, E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1568-1573.2001 · Cited by 316
Koren, E., Zuckerman, L., & Mire-Sluis, A. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378175 · Cited by 267
Self-citationShankar, G., Pendley, C., & Stein, K. E. (2007) · Nature Biotechnology · doi:10.1038/nbt1303 · Cited by 260
Self-citationJensen, D. M., McFarlane, I. G., Portmann, B. S., Eddleston, A. L. W. F., & Williams, R. (1978) · New England Journal of Medicine · doi:10.1056/nejm197807062990101 · Cited by 252
Gupta, S., Indelicato, S. R., Jethwa, V., Kawabata, T., Kelley, M., Mire-Sluis, A. R., Richards, S. M., Rup, B., Shores, E., Swanson, S. J., et al. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.12.004 · Cited by 241
Scientific and regulatory considerations on the immunogenicity of biologics
Shankar, G., Shores, E., Wagner, C., & Mire-Sluis, A. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2006.04.001 · Cited by 175
Self-citationWadhwa, M., Bird, C., Dilger, P., Gaines-Das, R. E., & Thorpe, R. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00206-0 · Cited by 104
Fineberg, N. S., Fineberg, S. E., Anderson, J. H., Birkett, M. A., Gibson, R. G., & Hufferd, S. (1996) · Diabetes · doi:10.2337/diab.45.12.1750 · Cited by 85
Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies
Geng, D., Shankar, G., Schantz, A., Rajadhyaksha, M., Davis, H. M., & Wagner, C. L. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.04.045 · Cited by 71
Self-citationZhao, J., Yang, R., Cui, Z., Chen, M., Zhao, M., & Wang, H. (2007) · Nephron Clinical Practice · doi:10.1159/000107803 · Cited by 40
Cited by
Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696
Phase 3 Study of Reslizumab in Patients With Poorly Controlled Asthma
Corren, J., Weinstein, S., Janka, L., Zangrilli, J., & Garin, M. (2016) · Chest · doi:10.1016/j.chest.2016.03.018 · Cited by 388
Shankar, G., Arkin, S., Cocea, L., Devanarayan, V., Kirshner, S., Kromminga, A., Quarmby, V., Richards, S., Schneider, C. K., Subramanyam, M., et al. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9599-2 · Cited by 353
Self-citationImmunogenicity to Therapeutic Proteins: Impact on PK/PD and Efficacy
Chirmule, N., Jawa, V., & Meibohm, B. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9340-y · Cited by 335
Ponce, R., Abad, L., Amaravadi, L., Gelzleichter, T., Gore, E., Green, J., Gupta, S., Herzyk, D., Hurst, C., Ivens, I. A., et al. (2009) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.03.012 · Cited by 270
Self-citation
Metadata
- Authors
- Shankar, G., Devanarayan, V., Amaravadi, L., Barrett, Y. C., Bowsher, R., Finco-Kent, D., Fiscella, M., Gorovits, B., Kirschner, S., Moxness, M., Parish, T., Quarmby, V., Smith, H., Smith, W., Zuckerman, L. A., & Koren, E.
- Venue
- Journal of Pharmaceutical and Biomedical Analysis
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 48
- Issue
- 5
- Pages
- 1267-1281
- ISSN
- 0731-7085 (ISSN-L)
- OpenAlex
- W1967295501
- Cited by
- 613
- References
- 22
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.